MYLAN TM 180 MYLAN TM 180 Pill - orange & white capsule/oblong, 21mm
Pill with imprint MYLAN TM 180 MYLAN TM 180 is Orange & White, Capsule/Oblong and has been identified as Temozolomide 180 mg. It is supplied by Mylan Pharmaceuticals Inc.
Temozolomide is used in the treatment of Glioblastoma Multiforme; Anaplastic Astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 180 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MYLAN TM 180 MYLAN TM 180
Temozolomide
- Imprint
- MYLAN TM 180 MYLAN TM 180
- Strength
- 180 mg
- Color
- Orange & White
- Size
- 21.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-5264 (Discontinued)
- Inactive Ingredients
-
silicon dioxide,
lactose anhydrous,
sodium starch glycolate type A potato,
stearic acid,
tartaric acid,
ammonia,
ferrosoferric oxide,
propylene glycol,
shellac,
gelatin,
titanium dioxide,
ferric oxide red,
ferric oxide yellow,
sodium lauryl sulfate
Note: Inactive ingredients may vary.
More about temozolomide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (10)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: alkylating agents
- En español
Patient resources
- Temozolomide oral/injection drug information
- Temozolomide (Intravenous) (Advanced Reading)
- Temozolomide (Oral) (Advanced Reading)
- Temozolomide Capsules
- Temozolomide Injection
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.